173 related articles for article (PubMed ID: 19653055)
1. Reciprocal effects of alpha-synuclein overexpression and proteasome inhibition in neuronal cells and tissue.
Dyllick-Brenzinger M; D'Souza CA; Dahlmann B; Kloetzel PM; Tandon A
Neurotox Res; 2010 Apr; 17(3):215-27. PubMed ID: 19653055
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.
Gerard M; Deleersnijder A; Daniëls V; Schreurs S; Munck S; Reumers V; Pottel H; Engelborghs Y; Van den Haute C; Taymans JM; Debyser Z; Baekelandt V
J Neurosci; 2010 Feb; 30(7):2454-63. PubMed ID: 20164329
[TBL] [Abstract][Full Text] [Related]
3. alpha-Synuclein expression levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines.
Martìn-Clemente B; Alvarez-Castelao B; Mayo I; Sierra AB; Dìaz V; Milán M; Fariñas I; Gómez-Isla T; Ferrer I; Castaño JG
J Biol Chem; 2004 Dec; 279(51):52984-90. PubMed ID: 15466467
[TBL] [Abstract][Full Text] [Related]
4. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
[TBL] [Abstract][Full Text] [Related]
5. Distinct alpha-Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH-SY5Y cells.
Pantazopoulou M; Brembati V; Kanellidi A; Bousset L; Melki R; Stefanis L
J Neurochem; 2021 Mar; 156(6):880-896. PubMed ID: 32869336
[TBL] [Abstract][Full Text] [Related]
6. Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.
Yshii LM; Denadai-Souza A; Vasconcelos AR; Avellar MC; Scavone C
J Neuroinflammation; 2015 Oct; 12():193. PubMed ID: 26502720
[TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells.
Hettiarachchi NT; Parker A; Dallas ML; Pennington K; Hung CC; Pearson HA; Boyle JP; Robinson P; Peers C
J Neurochem; 2009 Dec; 111(5):1192-201. PubMed ID: 19860837
[TBL] [Abstract][Full Text] [Related]
8. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.
Danzer KM; Krebs SK; Wolff M; Birk G; Hengerer B
J Neurochem; 2009 Oct; 111(1):192-203. PubMed ID: 19686384
[TBL] [Abstract][Full Text] [Related]
9. Activation of the immunoproteasome protects SH-SY5Y cells from the toxicity of rotenone.
Sun C; Mo M; Wang Y; Yu W; Song C; Wang X; Chen S; Liu Y
Neurotoxicology; 2019 Jul; 73():112-119. PubMed ID: 30904435
[TBL] [Abstract][Full Text] [Related]
10. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner.
Machiya Y; Hara S; Arawaka S; Fukushima S; Sato H; Sakamoto M; Koyama S; Kato T
J Biol Chem; 2010 Dec; 285(52):40732-44. PubMed ID: 20959456
[TBL] [Abstract][Full Text] [Related]
12. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
Qiao L; Hamamichi S; Caldwell KA; Caldwell GA; Yacoubian TA; Wilson S; Xie ZL; Speake LD; Parks R; Crabtree D; Liang Q; Crimmins S; Schneider L; Uchiyama Y; Iwatsubo T; Zhou Y; Peng L; Lu Y; Standaert DG; Walls KC; Shacka JJ; Roth KA; Zhang J
Mol Brain; 2008 Nov; 1():17. PubMed ID: 19021916
[TBL] [Abstract][Full Text] [Related]
14. Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn).
Batelli S; Peverelli E; Rodilossi S; Forloni G; Albani D
Neuroscience; 2011 Nov; 195(4):128-37. PubMed ID: 21906659
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells.
Perfeito R; Ribeiro M; Rego AC
Arch Toxicol; 2017 Mar; 91(3):1245-1259. PubMed ID: 27424009
[TBL] [Abstract][Full Text] [Related]
16. E46K Mutant α-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway.
Yan JQ; Yuan YH; Chu SF; Li GH; Chen NH
Molecules; 2018 Nov; 23(11):. PubMed ID: 30388770
[TBL] [Abstract][Full Text] [Related]
17. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.
Emmanouilidou E; Stefanis L; Vekrellis K
Neurobiol Aging; 2010 Jun; 31(6):953-68. PubMed ID: 18715677
[TBL] [Abstract][Full Text] [Related]
18. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
19. Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells.
Ko LW; Ko HH; Lin WL; Kulathingal JG; Yen SH
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1084-96. PubMed ID: 18957893
[TBL] [Abstract][Full Text] [Related]
20. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin-Proteasome System Activation.
Guo B; Zheng C; Cao J; Qiu X; Luo F; Li H; Lee SM; Yang X; Zhang G; Sun Y; Zhang Z; Wang Y
Neuromolecular Med; 2024 Apr; 26(1):9. PubMed ID: 38568291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
